A phase 1/2 clinical trial evaluating safety and immunogenicity
A phase 1/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults.
Leroux-Roels I, Leroux-Roels G, Clement F, Vandepapelière P, Vassilev V, Ledent E, Heineman TC. J Infect Dis.
2012 Oct;206(8):1280-9